Skip to main content
Adhish Agarwal
Rating: 4.9 of 5
( out of 45 reviews )

Adhish Agarwal, MD

Languages spoken: English, Hindi

Clinical Locations

Primary Location

University of Utah Hospital

Nephrology
50 N Medical Dr
Salt Lake City , UT 84132

Kolff Dialysis Center
423 Wakara Way
Salt Lake City , UT 84108
  • Adhish Agarwal, MD, is a Professor of Medicine in the Department of Medicine, Division of Nephrology and Hypertension at the University of Utah. After completing his medical school training at the University of Delhi (MAMC), he completed Internship and Residency training in Internal Medicine at Nassau University Medical Center in New York, and subsequently a Clinical Fellowship in Nephrology at the University of Utah in 2003. After his fellowship, he practiced Nephrology in Ogden, during which he also served as Medical Director for two University of Utah Dialysis units, as Chief Department of Medicine at McKay-Dee Hospital, as Medical Director for Intermountain Healthcare Acute Dialysis services for the Northern region, and also served as a Board Member of the Dialysis Research Foundation. He joined the University of Utah in June 2017. Since June 2020, he has also served as the Associate Chief of Medicine Service at the SLC VA Medical Center. He is board certified in Nephrology through the American Board of Internal Medicine.

    Dr. Agarwal’s clinical interests include taking care of patients with various kidney problems including glomerulonephritis, ADPKD, acute kidney injury, and dialysis, and enjoys interactions with his patients. His primary research interests include cardio-renal syndrome, renal physiology in heart failure, and hypertension.

    Board Certification

    American Board of Internal Medicine (Sub: Nephrology)
    Educational Commission for Foreign Medical Graduates

    Patient Rating

    Rating: 4.9 out of 5
    4.9 /5
    ( out of 45 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    UH HOSPITALS AND CLINICS
    Rating: 5 out of 5

    Clear explanation of my situation

    UH HOSPITALS AND CLINICS
    Rating: 5 out of 5

    He was wonderful and caring and took the time to explain to me what my med changes would be.

    UH HOSPITALS AND CLINICS
    Rating: 5 out of 5

    Dr. Agarwal has been so kind and taken his time to explain everything to my husband and I in detail. He has been upbeat and positive and helped to ease my worries. I really appreciate him and his staff, they have been awesome to work with!

    UH HOSPITALS AND CLINICS
    Rating: 5 out of 5

    Muy buen doctor trata al paciente con amabilidad

    UH HOSPITALS AND CLINICS
    Rating: 4 out of 5

    I have a hearing problem so his accent made it hard for me to easily understand him

    UH HOSPITALS AND CLINICS
    Rating: 5 out of 5

    Dr. Agrawal has always been great with me.

    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    De, Adish agarwal saved my life.

    UH HOSPITALS AND CLINICS
    Rating: 5 out of 5

    There is a possibility kidney problem might be result of medication. I appreciate ruling that out first before any additional test are performed. Thank you

    UH HOSPITALS AND CLINICS
    Rating: 5 out of 5

    Dr. Agarwal is always very thorough and takes the time to explain my test results and what is actually happening in my body. He gives me options for further testing to be done now or later, if he feels it can wait.

  • Adhish Agarwal, MD, is a Professor of Medicine in the Department of Medicine, Division of Nephrology and Hypertension at the University of Utah. After completing his medical school training at the University of Delhi (MAMC), he completed Internship and Residency training in Internal Medicine at Nassau University Medical Center in New York, and subsequently a Clinical Fellowship in Nephrology at the University of Utah in 2003. After his fellowship, he practiced Nephrology in Ogden, during which he also served as Medical Director for two University of Utah Dialysis units, as Chief Department of Medicine at McKay-Dee Hospital, as Medical Director for Intermountain Healthcare Acute Dialysis services for the Northern region, and also served as a Board Member of the Dialysis Research Foundation. He joined the University of Utah in June 2017. Since June 2020, he has also served as the Associate Chief of Medicine Service at the SLC VA Medical Center. He is board certified in Nephrology through the American Board of Internal Medicine.

    Dr. Agarwal’s clinical interests include taking care of patients with various kidney problems including glomerulonephritis, ADPKD, acute kidney injury, and dialysis, and enjoys interactions with his patients. His primary research interests include cardio-renal syndrome, renal physiology in heart failure, and hypertension.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Professor (Clinical)
    Academic Divisions Nephrology & Hypertension
    Board Certification
    American Board of Internal Medicine (Sub: Nephrology)
    Educational Commission for Foreign Medical Graduates

    Education history

    Professional Medical Medical School - University of Delhi, Maulana Azad Medical College M.D.
    Internship General Surgery - University of Delhi, Maulana Azad Medical College Intern
    Internship/Residency Internal Medicine - Nassau University Medical Center Intern/Resident
    Fellowship Nephrology - University of Utah School of Medicine Clinical Fellow

    Selected Publications

    Journal Article

    1. Malhotra R, Katz R, Jotwani V, Agarwal A, Cohen DL, Cushman WC, Ishani A, Killeen AA, Kitzman DW, Oparil S, Papademetriou V, Parikh CR, Raphael KL, Rocco MV, Tamariz LJ, Whelton PK, Wright JT Jr, Shlipak MG, Ix JH (2021). Estimated GFR Variability and Risk of Cardiovascular Events and Mortality in SPRINT (Systolic Blood Pressure Intervention Trial). Am J Kidney Dis, 78(1), 48-56. (Read full publication)
    2. Painter PL, Agarwal A, Drummond (2017). Physical Function and Physical Activity in Peritoneal Dialysis Patients. Peritoneal dialysis international, 37(6), 598-604. (Read full publication)
    3. Frodsham SG, Yu Z, Lyons AM, Agarwal A, Pezzolesi MH, Dong L, Srinivas TR, Ying J, Greene T, Raphael KL, Smith KR, Pezzolesi M (2019). The Familiality of Rapid Renal Decline in Diabetes. Diabetes, 68(2), 420-429. (Read full publication)
    4. Shah C, Srinivasan D, Erus G, Schmitt JE, Agarwal A, Cho ME, Lerner AJ, Haley WE, Kurella Tamura M, Davatzikos C, Bryan RN, Fan Y, Nasrallah I (2021). Changes in brain functional connectivity and cognition related to white matter lesion burden in hypertensive patients from SPRINT. Neuroradiology, 63(6), 913-924. (Read full publication)
    5. Singhania G, Ejaz AA, McCullough PA, Kluger AY, Balamuthusamy S, Dass B, Singhania N, Agarwal (2019). Continuation of Chronic Heart Failure Therapies During Heart Failure Hospitalization - a Review. Reviews in cardiovascular medicine, 20(3), 111-120. (Read full publication)
    6. Agarwal A, Wei G, Boucher R, Ahmed F, Beddhu (2021). Modification of the effects of intensive systolic blood pressure control on kidney outcomes by baseline body mass index. Nephrology (Carlton, Vic.), 26(4), 303-311. (Read full publication)
    7. Nyman HA, Agarwal A, Senekjian HO, Leypoldt JK, Cheung A (2018). Removal of vancomycin administered during dialysis by a high-flux dialyzer. Hemodialysis international. International Symposium on Home Hemodialysis, 22(3), 383-387. (Read full publication)
    8. Al-Rabadi L, Box T, Singhania G, Al-Marji C, Agarwal A, Hall I, Gordon CE, Tran (2018). Rationale for treatment of hepatitis C virus infection in end-stage renal disease patients who are not kidney transplant candidates. Hemodialysis international. International Symposium on Home Hemodialysis, 22 Suppl 1, S45-S52. (Read full publication)
    9. Agarwal A, Cheung A (2020). Mineralocorticoid Receptor Antagonists in ESKD. Clinical journal of the American Society of Nephrology, 15(7), 1047-1049. (Read full publication)
    10. Cho ME, Hansen JL, Sauer BC, Cheung AK, Agarwal A, Greene (2021). Heart Failure Hospitalization Risk associated with Iron Status in Veterans with CKD. Clinical journal of the American Society of Nephrology, 16(4), 522-531. (Read full publication)
    11. Agarwal A, Cheung AK, Ma J, Cho M, Li (2019). Effect of Baseline Kidney Function on the Risk of Recurrent Stroke and on Effects of Intensive Blood Pressure Control in Patients With Previous Lacunar Stroke: A Post Hoc Analysis of the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes). Journal of the American Heart Association, 8(16), e013098. (Read full publication)
    12. Agarwal A, Beddhu S, Boucher R, Rao V, Ramkumar N, Rodan AR, Fang J, Wynne BM, Drakos SG, Hanff T, Cheung AK, Fang J (2024). Evaluation of renal sodium handling in heart failure with preserved ejection fraction: A pilot study. Physiological reports, 12(9), e16033. (Read full publication)
    13. Pearce KE, Guo Y, Subhash S, Ftouni D, Visconti B, Wadhwa A, Agarwal A, Jia H, Shukla AM (2025). Decision Readiness and Determinants of Kidney Replacement Therapy among Veterans with Advanced Chronic Kidney Disease. . Clinical journal of the American Society of Nephrology,

    Letter

    1. Agarwal (2018). Evaluation and Management of Lower-Extremity Ulcers. The New England journal of medicine, 378(3), 302. (Read full publication)
    2. Agarwal (2017). Single-Nephron Glomerular Filtration Rate in Healthy Adults. The New England journal of medicine, 377(12), 1202. (Read full publication)